Salvage brachytherapy for locally recurrent prostate cancer after definitive radiotherapy – a multicentric French cohort by the SFRO brachytherapy group
Salvage BT provides encouraging disease control with an acceptable toxicity profile. Careful patient selection remains essential.
Authors
- Pierre Blanchard (ORCID: https://orcid.org/0000-0003-4785-3409)
- Korobnikov Ka
- Manon Kissel (ORCID: https://orcid.org/0000-0001-8255-4565)
- J M Cosset
- Mario Terlizzi (ORCID: https://orcid.org/0000-0001-8496-6918)
- Ousseynou Sarr (ORCID: https://orcid.org/0000-0002-5847-4984)
- Camille Verry (ORCID: https://orcid.org/0000-0002-9362-7624)
- R. Schiappa
- Y Meraouna
- Azzat Khoukaz
- J-M Hannoun-Levi
- Anne-Agathe Serre
- É. Martin (ORCID: https://orcid.org/0000-0002-2918-3117)
- Sofiane Hanaya
Institutions
- Université Côte d'Azur (FR)
- Centre Hospitalier Universitaire de Grenoble (FR)
- Institut Gustave Roussy (FR)
- Centre de Radiothérapie Bayard (FR)
- Centre Georges François Leclerc (FR)
- Centre Léon Bérard (FR)
- Agir Pour les Maladies Chroniques (FR)
- Centre Antoine Lacassagne (FR)
- Institut Curie (FR)
Publication Details
- Journal
- Radiotherapy and Oncology
- Published
- 2025-09-30
- DOI
- https://doi.org/10.1016/j.radonc.2025.111170
- Primary Topic
- Prostate Cancer Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 0.00